A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults

NCT04883333 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

LEO Pharma

Collaborators